Related Experiment Video

Updated: Jun 19, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K

What is 'chronic' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment

Angelo Valerio Marzano1,2, Carlo Alberto Maronese1,2, Anna Balato3

  • 1Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Expert Opinion on Biological Therapy
|May 2, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
IL-36neutrophilic dermatosispustular psoriasisspesolimabsubcutaneous

More Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

351

Related Experiment Videos

Last Updated: Jun 19, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.9K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

351

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Articles linked to this work by shared authors, journal, and citation graph.

Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection.

Antibodies (Basel, Switzerland)·2026

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

Journal of clinical medicine·2026

Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage.

Clinics and practice·2026

European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP.

Journal of clinical medicine·2026

Dopamine-replacing gene therapy for Parkinson's disease: biochemical background and current clinical experience.

Expert opinion on biological therapy·2026

Biologic therapies for adult chronic urticaria: what works, what doesn't, and why.

Expert opinion on biological therapy·2026

Threats to validity of the PESTO perispinal etanercept stroke trial: a document-based clinical trial evaluation.

Expert opinion on biological therapy·2026

An evaluation of denecimig for bleeding prophylaxis in hemophilia A.

Expert opinion on biological therapy·2026

Assessing the effectiveness of biologics in biologic-naïve patients with isolated small bowel Crohn's disease by double-balloon endoscopy.

Expert opinion on biological therapy·2026

Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort.

Expert opinion on biological therapy·2026

Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease.

Frontiers in neuroscience·2026

Young adult polysubstance use trajectories and later non-prescribed opioid use and drug use disorder symptoms: A propensity score-matched analysis.

Drug and alcohol dependence reports·2026

Updated Estimates of Agreement Between Dispensed Medications and Forensic Toxicology in Sweden.

Pharmacoepidemiology and drug safety·2026

Cannabis use is associated with increased risk of violence: A systematic review and meta-analysis.

Psychological medicine·2026

How frequently does parathyroidectomy and adjuvant treatment lead to clinically meaningful changes in bone mineral density? A multi-institutional study.

Surgery·2026

Simple LC-MS/MS Method for Ruxolitinib in Human Plasma and Its Clinical Application in Pediatric and Adult Patients.

Biological & pharmaceutical bulletin·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us